HTG Molecular Diagnostics, Inc. (HTGM), a provider of instruments, reagents, and services for molecular profiling applications, announced that it has entered into a research agreement with Centre Léon Bérard, which provides the framework for molecular profiling studies aimed to advance precision medicine. The initial project utilizes the HTG EdgeSeq Oncology Biomarker Panel to retrospectively characterize immunologic profiles from advanced malignant tumor samples collected in the ProfiLER study (ClinicalTrials.gov identifier NCT01774409).
Author Archive: AZBio
HTG Molecular Diagnostics and Daiichi Sankyo Complete Master Services Agreement
HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications, announced that it has entered into a master services agreement with Daiichi Sankyo Company, Limited (Daiichi Sankyo) for work to be performed in HTG’s VERI/O laboratory. The initial project includes the development of a custom assay for the detection of nearly 3,000 mRNA targets using the HTG EdgeSeq technology.Continue reading
Draft Legislation for User Fee Reauthorization Released on April 14, 2017
On April 14, 2017, the leaders of the Senate and House health committees released a discussion draft of bipartisan legislation reauthorizing the Food and Drug Administration user fee agreements. Continue reading
NuvOx Pharma receives $300K NHLBI Award
The NHLBI Grants NuvOx Pharma a $300k Grant to Study the Effects of their Oxygen Therapeutic on in Myocardial Infarction in a Pig Model.Continue reading
I-ACT for Children established to catalyze pediatric therapeutics clinical research & education
New non-profit institute to work with public and private stakeholders to enable research and education on innovative treatments to enhance healthcare for children.
Congresswoman Sinema Honored as BIO Legislator of the Year
Washington, D.C. (April 5, 2017) – The Biotechnology Innovation Organization (BIO) announced today its selection of Congresswoman Kyrsten Sinema (D-AZ) as a 2017 Legislator of the Year. Congresswoman Sinema will receive the award in conjunction with BIO’s Legislative Day Fly-In.
UA Startup Catalina Pharma Offers New Method to Treat Anesthesia-Induced Hypothermia
Tucson, Ariz. – Researchers at the University of Arizona College of Medicine-Tucson and Dignity Health St. Joseph’s Hospital and Medical Center – Phoenix have come up with a new method for treating the decrease in body temperature that occurs under anesthesia during surgery (anesthesia-induced hypothermia). The team, which includes anesthesiologist Amol Patwardhan, M.D., Ph.D., working with Frank Porreca, Ph.D., of the University of Arizona, and Andrej Romanovsky, M.D., Ph.D. at St. Joseph’s, have been investigating the utility of TRPV-1 antagonists to address this condition.Continue reading